Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Neurology (clinical),Neurology,Oncology
Link
http://link.springer.com/article/10.1007/s11060-017-2685-4/fulltext.html
Reference38 articles.
1. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996. https://doi.org/10.1056/NEJMoa043330
2. Weller M, Cloughesy T, Perry JR, Wick W (2013) Standards of care for treatment of recurrent glioblastoma–are we there yet? Neuro-Oncol 15:4–27. https://doi.org/10.1093/neuonc/nos273
3. International Agency for Research on Cancer (2016) WHO classification of tumours of the central nervous system, 4th edn. World Health Organization, Lyon
4. Lonjon N, Bauchet L, Duffau H et al (2010) Second surgery for glioblastoma. A 4-year retrospective study conducted in both the Montpellier and Nice Departments of Neurosurgery. A literature review. Neurochirurgie 56:36–42. https://doi.org/10.1016/j.neuchi.2009.11.013
5. De Bonis P, Fiorentino A, Anile C et al (2013) The impact of repeated surgery and adjuvant therapy on survival for patients with recurrent glioblastoma. Clin Neurol Neurosurg 115:883–886. https://doi.org/10.1016/j.clineuro.2012.08.030
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The cross-modality survival prediction method of glioblastoma based on dual-graph neural networks;Expert Systems with Applications;2024-11
2. Impact of body composition parameters, age, and tumor staging on gastric cancer prognosis;European Journal of Cancer Prevention;2024-08-13
3. Recursive partitioning analysis for survival stratification and early imaging prediction of molecular biomarker in glioma patients;BMC Cancer;2024-07-09
4. Prognostic Factors for Progression-free Survival and Overall Survival After Recurrence of Glioblastoma;Anticancer Research;2024-06-26
5. Do presenting symptoms predict treatment decisions and survival in glioblastoma? Real-world data from 1458 patients in the Swedish brain tumor registry;Neuro-Oncology Practice;2024-04-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3